Poseida Therapeutics Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Poseida Therapeutics Inc
TickerPSTX
CIK #0001661460
CUSIP70322H106
SectorLife Sciences - Biological Products, (No Disgnostic Substances)
Address9390 Towne Centre Drive Suite 200, San Diego, CA 92121
Source [EDGAR]
CIK Filing 2011 - 2024
[0001661460] 10-K
[0001661460] 10-Q
[0001661460] 3
[0001661460] 4
[0001661460] 5
[0001661460] 8-K
[0001661460] D
[0001661460] SC 13D
[0001661460] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Novartis Pharma AG Poseida Therapeutics Inc [2021-02-12] 9.6
Malin Life Sciences Holdings Ltd Poseida Therapeutics Inc [2021-02-03] 14.9
Pentwater Capital Management LP Poseida Therapeutics Inc [2020-12-28] 8.03
FMR LLC Poseida Therapeutics Inc [2020-08-10] 0.0
Form 3/4/5 Filer 2011 - 2024
Amado Rafael
Poseida Therapeutics, Inc.
Yarema Kristin
Gergen Mark J
Warner Brent
Mylet Johanna
Leonhardt Harry J
Ostertag Eric
Malin Life Sciences Holdings Ltd
Collins Cynthia
Corning Luke
Schmid John P.
Lloyd Marcea Bland
BAUM Charles M
Ingalls Kerry D.
Spear Matthew A.
Hirsch David
Novartis AG
Novartis Pharma AG
Murphy Sean
Malin Corp plc
Mackey Catherine J
Form 13F Holdings
Firm Period DFND Voting Shares
FMR LLC [2023-03-31] DFND 12,979,080.0 12,979,080.0
Pentwater Capital Management LP [2023-03-31] SOLE 5,975,000.0 5,975,000.0
SilverArc Capital Management LLC [2023-03-31] SOLE 2,689,301.0 2,689,301.0
EcoR1 Capital LLC [2023-03-31] SOLE 2,650,000.0 2,650,000.0
Vanguard Group Inc [2023-03-31] SOLE 0.0 2,302,145.0
BlackRock Inc. [2023-03-31] SOLE 1,868,199.0 1,889,823.0
Paradigm Biocapital Advisors LP [2023-03-31] SOLE 1,072,410.0 1,072,410.0
Aisling Capital Management LP [2023-03-31] SOLE 1,043,267.0 1,043,267.0
Acadian Asset Management LLC [2023-03-31] DFND 1,011,383.0 1,011,383.0
Cormorant Asset Management LP [2023-03-31] DFND 1,000,000.0 1,000,000.0
Millennium Management LLC [2023-03-31] SOLE 975,612.0 975,612.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 672,877.0 695,846.0
Susquehanna International Group LLP [2023-03-31] DFND 651,394.0 651,394.0
Renaissance Technologies LLC [2023-03-31] SOLE 341,031.0 603,200.0
Laurion Capital Management LP [2023-03-31] SOLE 545,700.0 545,700.0
Geode Capital Management LLC [2023-03-31] DFND 506,090.0 506,090.0
Morgan Stanley [2023-03-31] DFND 475,806.0 481,826.0
Two Sigma Investments LP [2023-03-31] SOLE 481,044.0 481,044.0
Marshall Wace LLP [2023-03-31] OTR 0.0 448,745.0
Wellington Management Group LLP [2023-03-31] DFND 0.0 372,285.0
Goldman Sachs Group Inc [2023-03-31] DFND 293,362.0 293,362.0
Cubist Systematic Strategies, LLC [2023-03-31] DFND 0.0 292,721.0
Qube Research & Technologies Ltd [2023-03-31] SOLE 0.0 277,168.0
Citadel Advisors LLC [2023-03-31] DFND 274,704.0 274,704.0
Charles Schwab Investment Management Inc [2023-03-31] SOLE 260,746.0 260,746.0
Advisory Services Network LLC [2023-03-31] SOLE 257,271.0 257,271.0
Jane Street Group LLC [2023-03-31] DFND 253,169.0 253,169.0
Bank of America Corp /DE/ [2023-03-31] DFND 0.0 252,148.0
State Street Corp [2023-03-31] DFND 234,467.0 234,467.0
HRT Financial LP [2023-03-31] DFND 191,064.0 191,064.0
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com